An Evening for Conversation. A Moment for Possibilities.
Individuals with Down syndrome are living longer than ever. For decades, this community has helped drive progress, from inclusion in schools and the workplace, to longer life expectancy, with NDSS alongside them every step of the way. Today, that progress brings new opportunities and challenges.
Down syndrome-associated Alzheimer’s disease (DS-AD) is one of the most urgent issues facing this generation. Advances in research, informed healthcare, and advocacy are creating an opening unlike anything we have seen before. It is a pivotal moment
Research alone cannot change lives, however. It takes informed families, prepared healthcare providers, strong clinical trial participation, effective policy, and the voices of individuals with Down syndrome.
This intimate evening brings together friends, partners and leaders, featuring a distinguished panel whose voices are helping to shape the future. Together, we will explore the barriers facing individuals with Down syndrome and what it takes to create a world where they thrive across the lifespan.
Discovery Evening California
Monday, November 2, 2026
5:30 – 8:30 p.m. | Program 6:30
Lido House, Newport Beach
Registration form below
Event Timeline
5:30 PM - WELCOME RECEPTION
6:45 PM - PROGAM AT A GLANCE:
- Welcome: Thriving across the lifespan
- Research: What does thriving look like in a world where we get Alzheimer’s disease right
- Community: CARE Down Syndrome and why informed healthcare matters
- Advocacy + Lived Experience: Having a voice in shaping the future
7:30 PM - MODERATED DISCUSSION
8:00 PM - DESSERT & CONTINUED CONVERSATION
Our community has never waited for progress to come to us. With NDSS serving as a connector, we are bringing the right people and ideas together to help shape what comes next.
Come be part of this important conversation and explore why getting this moment right matters.
Questions regarding the event? Please contact Deborah Still at 202-914-8398 | dstill@ndss.org
Moderator & Panelists
Kandi Pickard
Panelist
As CEO of NDSS, Kandi Pickard provides vision and leadership, working collaboratively with individuals and organizations to support the entire Down syndrome community. Her involvement began as a local volunteer and advocate after her youngest son, Mason, was born with Down syndrome. Thirteen years later, she leads NDSS with a focus on building community and keeping individuals with Down syndrome at the center of everything the organization does. Her vision includes expanding resources, programs, and support from diagnosis through adulthood, with a special focus on caregiving, public health, and aging adults.
Michael Rafii, MD, PhD
Panelist
Michael Rafii is a leading researcher in Alzheimer’s disease and Down syndrome. In addition to his role as Medical Director at ATRI, he is a Professor of Clinical Neurology at Keck School of Medicine. He is also an Associate Director of the NIH-funded Alzheimer’s Clinical Trials Consortium (ACTC), overseeing the safety and conduct of its portfolio of trials. He serves as Co-Director of the Clinical Core of the Alzheimer’s Disease Neuroimaging Initiative (ADNI), Co-Principal Investigator of the Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET) and leads the Alzheimer’s Clinical Trials Consortium–Down Syndrome (ACTC-DS).
Brian Chicoine, MD
Panelist
With more than 35 years of experience, Dr. Brian Chicoine has dedicated his career to advancing care for individuals with Down syndrome and other intellectual disabilities. He co-founded the Adult Down Syndrome Center in 1992 and now serves as its Medical Director. The Center has served more than 6,000 adolescents and adults with Down syndrome. He has written and presented extensively on the health and psychosocial needs of individuals with Down syndrome and is a founding partner and clinical leader for NDSS’ CARE Down Syndrome, contributing evidence-based resources for healthcare professionals.
Kristi Golden
Panelist
Kristi Golden has been a leader in the Down syndrome community for more than 25 years. Following the birth of her son, Benjamin, she became deeply involved with the Down Syndrome Association of Orange County, serving in various roles. Kristi has worked with hundreds of families and individuals with Down syndrome across the lifespan and brings a unique blend of community experience, education, leadership, and systems thinking to her work. She also brings her perspective as a parent and community advocate to national conversations about Down syndrome and Alzheimer’s disease, including the recent NDSS sponsored FDA Patient-Focused Drug Development (PFDD) meeting.
Benjamin Golden
Panelist
Benjamin Golden is a 33-year-old self-advocate, aspiring actor, and multidisciplinary creative artist who lives independently in Irvine, California. He studies acting, ballet, and clogging and is an avid photographer, musician, and sports enthusiast. Benjamin is featured in five Dhar Mann YouTube videos through Changing Lives Productions and is frequently seen with a video camera or his Canon in hand, capturing and recording events for the Down Syndrome Association of Orange County. He was honored as the organization’s Volunteer of the Year in 2022 and later served as a paid intern. He completed a certificate program in Music Production at Coastline College and continues to pursue opportunities in arts and entertainment. Benjamin also participates in the ABC-DS research program at UC Irvine and serves as a co-researcher with the Rubenstein Lab’s DS TO THE MAX study.
Liz Head, MA, PhD
Moderator
Dr. Elizabeth Head is the Dean’s Professor and Vice Chair for Research in the Department of Pathology & Laboratory Medicine. She has dedicated more than 25 years to the study of aging and Alzheimer’s disease, with a focus on individuals with Down syndrome. Her laboratory uses multidisciplinary approaches to identify targets for interventions to slow or prevent the development of Alzheimer’s disease in individuals with Down syndrome. Dr. Head received a Master of Psychology and a PhD in Neuroscience from the University of Toronto, Canada. She completed postdoctoral training at the Institute for Memory Impairments and Neurological Disorders (UCI MIND) at the University of California, Irvine.